Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications how zoonotic disease surveillance can influence evidence based policy decisions one
… Insights Group. RTI earned four out of five stars, based on evaluation in eight categories: company image, … Solutions. “We are honored to be recognized by Newsweek as one of America's Greatest Workplaces for 2023, as we truly … and supported in our shared commitment to our mission.” “How do you find a great workplace—one that treats employees …
… published in Pediatrics give us an updated picture of how well childhood immunizations prevent disease and the economic impact of this disease prevention. … benefits of the studied vaccines. Read more about why and how these studies were conducted and their results by …
… declined sharply by early 2016. Similarly, other rituximab-based combination immunochemotherapies declined during the … shifting as treatment guidelines change. Learn more about how RTI Health Solutions can help you with retrospective cohort studies or any …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… data sources—using real-world data to generate real-world evidence (RWE). We have extensive experience in perinatal … typically required by regulatory authorities, so you can confidently partner with us to conduct the regulatory RWE … format or transformed into a common data model. Our team can also assist you with studies to describe the natural …
… voice in drug development and has issued new guidelines on how to do so. At the same time, the health care industry has … in new cancer treatment research. To better understand how PRO measures have been incorporated into research over … remained relatively stable at about 16%. However, at least one-third of phase three and almost half of phase two trials …
… hurdles that are present. Our experts in market access can help you anticipate, develop, and communicate critical … have collaborated with our clients to develop and present evidence to demonstrate the value of their medical devices … measures that will be critical in payer reimbursement decisions. Our experience includes: Cardiovascular devices …
… 2 and 3 clinical trials for the treatment of numerous rare disease indications (chronic inflammatory demyelinating … (BP), idiopathic inflammatory myositis (IIM), thyroid eye disease (TED), dermatomyositis, and scleroderma). As they … an experienced partner to help ensure they had robust evidence to support optimal market access. OUR APPROACH For …
… Read the other two articles here: Part 1: What Factors Influence Health Equity - or Inequity? Part 2: Advancing … those from the American Community Survey, Centers for Disease Control and Prevention, Opportunity Atlas, and … improve health equity and reduce disparities. Not only can RTI Rarity’s LSI scores identify socially vulnerable …
15th European Public Health Conference 2022 (EPH) Share on: Wednesday, November 9 - Saturday, November 12, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 15th European Public Health Conference …